Methodological Framework and Reproducible R Code for the Five-Layer Comorbidity-Aware Endometriosis AI Pipeline

Other OA: green CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-18 ⓘ

This paper presents a five-layer, reproducible R framework for validating comorbidity-aware endometriosis AI models against spectrum bias and phenotypic overlap with IBS and IBD using generative simulation and regulatory-aligned metrics.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-18 · read from full text ⓘ

This paper presents a methodological framework and reproducible R code for an artificial intelligence pipeline designed to address epidemiological spectrum bias and phenotypic overlap between endometriosis, irritable bowel syndrome, and inflammatory bowel disease. The proposed five-layer validation approach includes generative simulation of patient data, predictive modeling using random forests calibrated for concurrent conditions, safety mechanisms for out-of-distribution rejection, and comprehensive evaluation metrics including fairness auditing. The authors provide fully annotated scripts to ensure regulatory alignment with FDA standards and TRIPOD+AI guidelines for software as a medical device. This paper is centrally about endometriosis — specifically focusing on improving the accuracy and fairness of AI diagnostic pipelines by accounting for comorbidities that mimic its symptoms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

This repository contains the detailed Supplementary Methods (Methodological Framework and Simulation Architecture for the Comorbidity-Aware Endometriosis AI Pipeline) and the fully annotated, reproducible R script accompanying the manuscript: "Epidemiological spectrum bias in endometriosis AI: a simulation-based perspective and a comorbidity-aware validation framework". Methodological Summary: To address epidemiological spectrum bias and phenotypic overlap between endometriosis (ENDO), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), we provide a five-layer, regulatory-aligned (FDA SaMD & TRIPOD+AI) validation framework: Layer 1 (Generative):Conditional Gaussian copula simulation calibrated to literature-derived age and ethnicity marginals (Bougie et al., BJOG 2019) and multi-organ biomarker profiles (pelvic pain, GI dysfunction, hs-CRP). Layer 2 (Predictive):Random forest classifiers trained on referral-centre cohorts. Layer 3 (Calibration): Multivariate Vector Platt Scaling adjusting ENDO logits for concurrent IBS/IBD confounding. Layer 4 (Safety): Dual-tier deferral mechanism combining Mahalanobis distance out-of-distribution (OOD) rejection and ambiguity deferral. Layer 5 (Evaluation):30-iteration Monte Carlo external validation auditing discrimination (ROC/DeLong), calibration (ECE, Brier score), clinical utility (Decision Curve Analysis), and race-stratified fairness. Software Requirements: Before running the script, users must install the following required CRAN packages: tidyverse (data manipulation and piping, MASS (multivariate normal generation via mvrnorm for the Gaussian copula), ranger (fast random forest modelling), scales (graphical scaling and formatting), ggplot2(publication-grade data visualisation), and patchwork (multi-panel figure composition).
Full text 1,958 characters · extracted from oa-doi-fallback · click to expand
Methodological Framework and Reproducible R Code for the Five-Layer Comorbidity-Aware Endometriosis AI Pipeline Authors/Creators Description This repository contains the detailed Supplementary Methods (Methodological Framework and Simulation Architecture for the Comorbidity-Aware Endometriosis AI Pipeline) and the fully annotated, reproducible R script accompanying the manuscript: "Epidemiological spectrum bias in endometriosis AI: a simulation-based perspective and a comorbidity-aware validation framework". Methodological Summary: To address epidemiological spectrum bias and phenotypic overlap between endometriosis (ENDO), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), we provide a five-layer, regulatory-aligned (FDA SaMD & TRIPOD+AI) validation framework: Layer 1 (Generative):Conditional Gaussian copula simulation calibrated to literature-derived age and ethnicity marginals (Bougie et al., BJOG 2019) and multi-organ biomarker profiles (pelvic pain, GI dysfunction, hs-CRP). Layer 2 (Predictive):Random forest classifiers trained on referral-centre cohorts. Layer 3 (Calibration): Multivariate Vector Platt Scaling adjusting ENDO logits for concurrent IBS/IBD confounding. Layer 4 (Safety): Dual-tier deferral mechanism combining Mahalanobis distance out-of-distribution (OOD) rejection and ambiguity deferral. Layer 5 (Evaluation):30-iteration Monte Carlo external validation auditing discrimination (ROC/DeLong), calibration (ECE, Brier score), clinical utility (Decision Curve Analysis), and race-stratified fairness. Software Requirements: Before running the script, users must install the following required CRAN packages: tidyverse (data manipulation and piping, MASS (multivariate normal generation via mvrnorm for the Gaussian copula), ranger (fast random forest modelling), scales (graphical scaling and formatting), ggplot2(publication-grade data visualisation), and patchwork (multi-panel figure composition).

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-11-20T06:09:37.170340+00:00
License: CC0 · commercial use OK